Status:
COMPLETED
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Conditions:
Non Small Cell Lung Cancer
Secondary Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a Phase 3 study aimed at investigating the effects of a personalized exercise program (PEP) in NSCLC patients (stage I, II, IIIa) and secondary lung cancer patients undergoing surgical treatme...
Detailed Description
This is a Phase 3 study aimed at investigating the effects of a personalized exercise program (PEP) in NSCLC patients (stage I, II, IIIa) and secondary lung cancer patients undergoing surgical treatme...
Eligibility Criteria
Inclusion
- Male or female subject aged ≥ 18 years.
- Diagnosis of primary lung cancer stage I, II, or IIIa OR secondary lung cancer.
- Disease amenable to surgical resection in the opinion of the treating surgeon.
- Patients must be able to follow directions and complete questionnaires and exercise diaries in English.
- Patients must agree to be randomly assigned to either Intervention or Control Group.
Exclusion
- Deemed ineligible for surgery by the enrolling physician
- Abnormalities on screening physical exam judged by study physicians or supervising physical therapist to contraindicate participation in exercise program compliance.
- Alcohol or drug abuse as judged by study physicians.
- Significant mental or emotional problems that would interfere with study participation will be assessed by the NCCN Distress Thermometer. Any value higher than 7 will trigger further intervention, but ultimately enrollment into the clinical trial will be determined by the enrolling physician.
Key Trial Info
Start Date :
November 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03306992
Start Date
November 7 2017
End Date
May 31 2022
Last Update
June 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huntsman Cancer Institute
Salt Lake City, Utah, United States, 84112